In previous studies of HNSCC, FGFR1 amplification has been reported in 3 to 17% of cases, and FGFR1 protein overexpression has been identified in about 11–82% of cases [12–18]. The gene discussed is FGFR1; the disease is head and neck squamous cell carcinoma.